Myocardial Injury in Rheumatic Diseases: Immune and Microcirculatory and Molecular Mechanisms of Cardiomyopathies
International Journal of Molecular Sciences · 18.06.2026 · 27 (12) · 5513
DOI: 10.3390/ijms27125513 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.06.2026. Verfasst von Mateusz Lucki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department and Clinic of Cardiology, University of Medical Sciences, 60-545 Poznań, Poland. Hauptthemen laut MEDLINE: Rheumatic Diseases, Microcirculation, Cardiomyopathies, Myocardium. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immune-mediated myocardial injury is an important yet underrecognized manifestation of systemic rheumatic diseases and represents a biologically heterogeneous process extending beyond traditional cardiovascular complications such as pericardial disease or accelerated atherosclerosis. This review aimed to summarize current evidence regarding the molecular mechanisms underlying autoimmune myocardial injury and propose an integrated pathogenic framework. A structured narrative review of the literature was performed, focusing on molecular and cellular mechanisms, disease-specific pathogenic pathways, advances in cardio-immunology, and contemporary diagnostic approaches in autoimmune myocardial disease. Current evidence indicates that myocardial injury in rheumatic diseases results from complex interactions involving autoantibody-mediated injury, immune complex deposition, endothelial dysfunction, coronary microvascular dysfunction, dysregulated innate and adaptive immunity, oxidative stress, mitochondrial dysfunction, immunometabolic reprogramming, and regulated cardiomyocyte death. These mechanisms contribute to heterogeneous clinical manifestations, including myocarditis, arrhythmias, inflammatory cardiomyopathy, and heart failure. An integrated immune–microvascular–immunometabolic framework may represent a central mechanism driving myocardial injury and progression to inflammatory cardiomyopathy, supporting earlier diagnosis, improved risk stratification, and the development of precision therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department and Clinic of Cardiology, University of Medical Sciences, 60-545 Poznań, Poland.
- Clinical Rehabilitation Laboratory, Department of Rehabilitation and Physiotherapy, University of Medical Sciences, 60-545 Poznań, Poland.
- Department of Rheumatology, Rehabilitation and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznań, Poland.
ORCID-Profile: Ewa Lucka, Bogna Grygiel-Górniak, Przemysław Mitkowski
Zitieren
APA
Lucki, M., Lucka, E., Grygiel-Górniak, B., Iwańczyk, S., Mitkowski, P., & Lesiak, M. (2026). Myocardial Injury in Rheumatic Diseases: Immune and Microcirculatory and Molecular Mechanisms of Cardiomyopathies. International Journal of Molecular Sciences, 27(12), 5513. https://doi.org/10.3390/ijms27125513
Vancouver
Lucki M, Lucka E, Grygiel-Górniak B, Iwańczyk S, Mitkowski P, Lesiak M. Myocardial Injury in Rheumatic Diseases: Immune and Microcirculatory and Molecular Mechanisms of Cardiomyopathies. International Journal of Molecular Sciences. 2026;27(12):5513. doi:10.3390/ijms27125513
BibTeX
@article{Lucki2026,
author = {Lucki, Mateusz and Lucka, Ewa and Grygiel-Górniak, Bogna and Iwańczyk, Sylwia and Mitkowski, Przemysław and Lesiak, Maciej},
title = {Myocardial Injury in Rheumatic Diseases: Immune and Microcirculatory and Molecular Mechanisms of Cardiomyopathies},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5513},
doi = {10.3390/ijms27125513}
}
EUVIMED